SCHEMBL7654247

SCHEMBL7654247

CC1=C(C=O)CCCC1O

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
UGT2B17 O75795 2/20 0.35
GAA P10253 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4418524 0.77 CA1 (0.41)
SCHEMBL3668700 0.77 CA1 (0.41)
SCHEMBL9852673 0.75
SCHEMBL7662301 0.71
SCHEMBL4017056 0.70
SCHEMBL7911661 0.70 CNR2 (0.33)
SCHEMBL9593863 0.70 KDM1A (0.36)
SCHEMBL14394191 0.69
SCHEMBL3380327 0.68 TRIM24 (0.35)
SCHEMBL1784489 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6384045-B1 TREATMENT OF ALZHEIMER'S DISEASE AND ANTICANCER AGENTS KANSAS STATE UNIVERSITY RESEARCH FOUNDATION 2002-05-07 US disclosed
US-5958970-A ENZYME INHIBITORS OF ACETYLCHOLINESTERASE (ACHE) AND ACYL-COA:CHOLESTEROL ACYLTRANSFERASE (ACAT); USED IN THE TREATMENT OF ALZHEIMER'S DISEASE, ATHEROSCLEROSIS AND HYPERCHOLESTEROLEMIA KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 1999-09-28 US disclosed
WO-1998039010-A1 TRICYCLIC AND TETRACYCLIC PYRONES KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 1998-09-11 WO disclosed